EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Engineered Lactiplantibacillus plantarum and Levilactobacillus brevis utilizing ribonucleoprotein-mediated editing for inactivation of hemolysin gene

Hea Joon Kim, Min Young Kwon, Seongbong Song, Seong Won Cheon, Hyo Jin Kim

World Journal of Microbiology and Biotechnology · 2025-10 · 41 (10)

DOI: 10.1007/s11274-025-04598-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Microbiology and Biotechnology, online erschienen am 13.10.2025. Verfasst von Hea Joon Kim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of International Agricultural Technology, Seoul National University, Pyeongchang, 25354, Republic of Korea. Hauptthemen laut MEDLINE: Gene Editing, Ribonucleoproteins, Hemolysin Proteins, Lactiplantibacillus plantarum. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Seoul National University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lactiplantibacillus plantarum and Levilactobacillus brevis are widely used probiotics with significant potential as chassis organisms for probiotic engineering. However, their bioengineering remains underdeveloped compared to that of other probiotic bacteria due to the limited availability of genetic tools. Although CRISPR-Cas systems have shown promise for genome editing in Lactobacillus species, strain- or site-specific targeting challenges must be overcome to enhance their broader applicability. This study aimed to develop a novel editing system with reduced dependency on plasmids and antibiotics in L. plantarum WCFS1, L. plantarum SPC 72 − 1 and L. brevis SPC-SNU 70 − 2 using a Cas9-gRNA ribonucleoprotein (RNP) complex. Although the hlyIII gene has been annotated as a hemolysin-related gene in several Lactobacillus genomes, no functional hemolytic activity has been definitively demonstrated to date. In this study, hlyIII was selected as a target to evaluate genome editing efficiency and to assess its potential relevance to strain safety. To construct Δ hlyIII strains, the RNP complex targeting hlyIII was separately transformed with recombinase RecE/T and double-stranded donor DNA. As a result, Δ hlyIII mutants were obtained under optimized electroporation conditions. Sequencing analysis revealed a 50 bp deletion and the introduction of a stop codon in hlyIII across all mutant strains. The hemolytic activity test showed a reduction in free hemoglobin levels in the ΔhlyIII strains compared to the wild type: 27.0%, 74.3%, and 5.0% in L. plantarum WCFS1, L. plantarum SPC 72 − 1, and L. brevis SPC-SNU 70 − 2, respectively. These results suggest strain-dependent differences in hemolytic activity and indicate that inactivation of hlyIII may contribute to reduced hemolysis, although further validation is needed to clarify its functional role. In conclusion, the hlyIII gene was successfully edited in L. plantarum and L. brevis using Cas9-gRNA ribonucleoprotein-mediated editing, demonstrating the feasibility of this genome editing platform for application in probiotic strains. Graphical abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gene EditingRibonucleoproteinsHemolysin ProteinsLactiplantibacillus plantarumLactobacillusCRISPR-Cas SystemsProbioticsBacterial ProteinsPlasmidsRNA, Guide, CRISPR-Cas Systems

Stichwörter der Autor:innen

CRISPR/Cas9Genome editingHemolysinLactic acid bacteriaRibonucleoprotein

Substanzen

RibonucleoproteinsHemolysin ProteinsBacterial ProteinsRNA, Guide, CRISPR-Cas Systems

Autor:innen und Institutionen

  • Graduate School of International Agricultural Technology, Seoul National University, Pyeongchang, 25354, Republic of Korea.
  • Institutes of Green Bio Science and Technology, Seoul National University, Pyeongchang, 25354, Republic of Korea.
  • Research Institute of Food and Biotechnology, SPC Group Co, 1 Gwanak- ro, Gwanak-gu, Seoul, 08826, Republic of Korea.
  • Graduate School of International Agricultural Technology, Seoul National University, Pyeongchang, 25354, Republic of Korea. erythritol@snu.ac.kr.
  • Institutes of Green Bio Science and Technology, Seoul National University, Pyeongchang, 25354, Republic of Korea. erythritol@snu.ac.kr.

Förderung

  • Seoul National University

Zitieren

APA

Kim, H. J., Kwon, M. Y., Song, S., Cheon, S. W., & Kim, H. J. (2025). Engineered Lactiplantibacillus plantarum and Levilactobacillus brevis utilizing ribonucleoprotein-mediated editing for inactivation of hemolysin gene. World Journal of Microbiology and Biotechnology, 41(10). https://doi.org/10.1007/s11274-025-04598-y

Vancouver

Kim HJ, Kwon MY, Song S, Cheon SW, Kim HJ. Engineered Lactiplantibacillus plantarum and Levilactobacillus brevis utilizing ribonucleoprotein-mediated editing for inactivation of hemolysin gene. World Journal of Microbiology and Biotechnology. 2025;41(10). doi:10.1007/s11274-025-04598-y

BibTeX
@article{Kim2025,
  author = {Kim, Hea Joon and Kwon, Min Young and Song, Seongbong and Cheon, Seong Won and Kim, Hyo Jin},
  title = {Engineered Lactiplantibacillus plantarum and Levilactobacillus brevis utilizing ribonucleoprotein-mediated editing for inactivation of hemolysin gene},
  journal = {World Journal of Microbiology and Biotechnology},
  year = {2025},
  volume = {41},
  number = {10},
  doi = {10.1007/s11274-025-04598-y}
}
Kostenlos starten →